Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 4
ClinicalTrials.gov
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis
INTERVENTIONAL
Inicio: 1 de ago de 2003
ID: NCT00153062
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)
INTERVENTIONAL
Inicio: 30 de abr de 2025
ID: NCT06948422
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension
INTERVENTIONAL
Inicio: 18 de oct de 2019
ID: NCT03958877
Completado
Fase 4
ClinicalTrials.gov
A 14-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study To Evaluate The Safety And Efficacy Of Pregabalin (150mg-600mg/Day) Using A Flexible Optimal Dose Schedule In Patients With Painful Diabetic Peripheral Neuropathy (DPN).
INTERVENTIONAL
Inicio: 1 de ene de 2005
ID: NCT00156078
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants With Early Alzheimer's Disease
INTERVENTIONAL
Inicio: 16 de jul de 2025
ID: NCT07033494
Completado
ClinicalTrials.gov
A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)
OBSERVATIONAL
Inicio: 19 de nov de 2013
ID: NCT02047097
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)
INTERVENTIONAL
Inicio: 18 de jul de 2025
ID: NCT06929273
Completado
Fase 3
ClinicalTrials.gov
Six-month, Randomized, Open-label, Parallel-group Comparison of the Insulin Analog SAR342434 to Humalog® in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine
INTERVENTIONAL
Inicio: 1 de ene de 2015
ID: NCT02294474
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of a Heterologous Vaccine Regimen of Ad26.Mos4.HIV and Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals
INTERVENTIONAL
Inicio: 31 de oct de 2019
ID: NCT03964415
Completado
Fase 4
ClinicalTrials.gov
CONFIDENCE: A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Treated With Subcutaneous Injections of Copaxone(R) (Glatiramer Acetate) 40 mg/mL Three Times a Week Compared to 20 mg/mL Daily
INTERVENTIONAL
Inicio: 10 de ago de 2015
ID: NCT02499900
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Double-blind, Placebo-controlled Study Evaluating Efficacy and Safety of Riliprubart in Participants With Refractory Chronic Inflammatory Demyelinating Polyneuropathy
INTERVENTIONAL
Inicio: 12 de jul de 2024
ID: NCT06290128
Reclutando
Fase 3
ClinicalTrials.gov
Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine
INTERVENTIONAL
Inicio: 1 de dic de 2021
ID: NCT05164172
Completado
ClinicalTrials.gov
Diagnostic Accuracy of The Water Immersion Wrinkle Test for the Diagnosis of Small Fiber Neuropathy
OBSERVATIONAL
Inicio: 1 de nov de 2024
ID: NCT07255573
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
INTERVENTIONAL
Inicio: 6 de may de 2025
ID: NCT06747351
Completado
Fase 3
ClinicalTrials.gov
An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00407095
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab With or Without Bevacizumab Compared With Standard of Care as Firstline Maintenance Treatment for Participants With Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer With PD-L1 CPS Greater Than or Equal to 1 (TroFuse-036/GOG-3123/ENGOT-cx22)
INTERVENTIONAL
Inicio: 19 de ene de 2026
ID: NCT07216703
Completado
Fase 2
ClinicalTrials.gov
A Dose-ranging, Randomized, Double-blind , Placebo-controlled Study of the Effect of RO5313534, Used as add-on Therapy to Donepezil, on Cognitive Function in Patients With Mild to Moderate Symptoms of Alzheimer's Disease
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00884507
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00089804
Completado
ClinicalTrials.gov
TOP: TYSABRI Observational Program
OBSERVATIONAL
Inicio: 29 de jun de 2007
ID: NCT00493298
Completado
ClinicalTrials.gov
TRANSformá tu Salud Dejando de Fumar: Advancing Smoking Cessation Among Transgender
INTERVENTIONAL
Inicio: 23 de sept de 2024
ID: NCT07099287
Anterior
1
...
28
29
30
...
434
Siguiente
Filtros